Fraser Russell obtained his B.S. degree with major in biochemistry from Deakin University, Australia (1987). He studied the regulation of cardiac ß-adrenoceptors in Professor Roger Summers’ laboratory, in the Department of Pharmacology, University of Melbourne, obtaining his Ph.D. degree in 1994. In 1994, he traveled to the UK where he took a postdoctoral position with Dr. Anthony Davenport in the Clinical Pharmacology Unit, University of Cambridge, UK (1994–1998), studying secretory pathways involved in the release of endothelin from human endothelial cells. This was followed by postdoctoral studies at the University of Otago, New Zealand (1998–2000), returning to Australia as a Research Fellow at The Prince Charles Hospital, University of Queensland, Australia studying the effects of the peptide Urotensin-II in human heart and blood vessels (2000–2004). Dr. Russell is currently a Senior Lecturer in biochemical pharmacology at the University of the Sunshine Coast (since 2005), with continued research interests in cardiovascular pharmacology, including the study of mechanisms for the health benefits of omega-3 fatty acids. He was the recipient of www.UniJobs.com.au Lecturer of the Year Award 2007 for the University of the Sunshine Coast and is currently the Faculty Higher Degree by Research Coordinator and Member of the University Animal Ethics Committee. He is an Active Member of the Australasian Society for Clinical and Experimental Pharmacologists and Toxicologists (ASCEPT; since 1989) and is a Member of the Editorial Board of ISRN Cardiology (since 2011).
Biography Updated on 7 February 2011